Post COVID Pulmonary Fibrosis: What, Why and Whom?

Arup Halder

Abstract: Post COVID-19 pulmonary fibrosis is a new condition which is being recognized increasingly in few patients of COVID diseases. Though the actual prevalence is still unknown, but more patients are being detected of having this condition with increasing number of cases. Patients usually present with persistent shortness of breath even after recovery from other COVID related symptoms. The HRCT shows organizing pneumonia, traction bronchiectasis and ground glass opacities (GGOs). Injury to Type II Pneumocytes by the virus may be the inciting event. The treatment of the condition is still unknown, but various drugs have been tried.

Keywords: Idiopathic Pulmonary Fibrosis, IPF, Non Specific Interstitial Pneumonia, NSIP, Organizing Pneumonia, COP, Bronchiolitis Obliterens Organizing Pneumonia, (BOOP, Organizing Pneumonia, Pneumocytes, Epithelial Type II Pneumocyte Dysfunction, Epithelial Type II Pneumocyte Dysfunction

How to Cite?: Arup Halder, "Post COVID Pulmonary Fibrosis: What, Why and Whom?", Volume 10 Issue 7, July 2021, International Journal of Science and Research (IJSR), Pages: 1217-1223, https://www.ijsr.net/getabstract.php?paperid=SR21723210021, DOI: https://dx.doi.org/10.21275/SR21723210021